Brief: Novozymes Q4 EBITDA DKK 1,320 Million
Feb 01 (Reuters) - Novozymes Q4 gross margin 54.3%. * Q4 net income DKK 695 million vs. estimate DKK 918 million * Q4 EBIT margin 20.7% * Q4 EPS DKK 2.52 * Q4 EBIT DKK 955 million * Q4 sales DKK 4,603 million vs. estimate DKK 4,630 million
Recent news on Novozymes A/S
See all newsGivaudan jumps on fragrance outperformance; peers follow
Europe Research Roundup: IWG, Londonmetric, Sartorius
Brief: Novonesis To Build Next Generation Enzyme Production Facility In India
Next cycle in ingredient makers sector belongs to biotech, Jefferies says
Europe Research Roundup: DSM-Firmenich, Merck, Orsted